Results 91 to 100 of about 15,183 (185)

The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden

BMC Musculoskeletal Disorders, 2012
Background This paper presents the model and results to evaluate the use of teriparatide as a first-line treatment of severe postmenopausal osteoporosis (PMO) and Glucocorticoid-induced osteoporosis (GIOP).
Murphy Daniel R, Smolen Lee J, Klein Timothy M, Klein Robert W   +3 more
doaj   +1 more source

Idiopathic osteoporosis in men [PDF]

, 2013
Over the last decade, the increasingly significant problem of osteoporosis in men has begun to receive much more attention than in the past. In particular, recent observations from large scale population studies in males led to an advance in the ...
Bilezikian, JP, Gennari, L
core   +1 more source

A randomized controlled trial of teriparatide for accelerating bone union and improving clinical outcomes in patients with pertrochanteric fracture fixation

Scientific Reports
This prospective, double-blind, placebo-controlled, randomized trial evaluated the effects of teriparatide following pertrochanteric fracture fixation on bone healing and clinical outcomes.
Chotetawan Tanavalee, Srihatach Ngarmukos, Chavarin Amarase, Saran Tantavisut, Nonn Jaruthien, Aree Tanavalee   +5 more
doaj   +1 more source

Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw [PDF]

, 2016
Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) is an intractable, though rare, complication in cancer patients with bone metastases and patients with osteoporosis who are treated with antiresorptive agents, including bisphosphonates and ...
Akira Taguchi, Hiroaki Ohta, Hiroshi Hagino, Masahiro Urade, null null, Satoru Toyosawa, Satoshi Soen, Shunji Takahashi, Takahiko Shibahara, Toshihiko Nagata, Toshitsugu Sugimoto, Toshiyuki Yoneda   +11 more
core   +1 more source

Role of teriparatide in treatment of glucocorticoid-induced osteoporosis

Therapeutics and Clinical Risk Management, 2010
Arthur N Lau, Jonathan D AdachiDivision of Rheumatology and Department of Medicine, St Joseph’s Healthcare and McMaster University, Hamilton, Ontario, CanadaAbstract: Glucocorticoids are commonly used in various fields within medicine.
Arthur N Lau, Jonathan D Adachi
doaj  

Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness [PDF]

, 2019
Breast cancer bone metastases often cause a debilitating non-curable condition with osteolytic lesions, muscle weakness and a high mortality. Current treatment comprises chemotherapy, irradiation, surgery and anti-resorptive drugs that restrict but do ...
Brandt, Diana, Hesse, Eric, Pamperin, Jenny, Saito, Hiroaki, Schröder, Saskia, Taipaleenmäki, Hanna   +5 more
core   +1 more source

No effect of teriparatide on migration in total knee replacement: A randomized controlled trial involving 50 patients

Acta Orthopaedica, 2017
Background and purpose — Aseptic loosening is a main cause of late revision in total knee replacement (TKR). Teriparatide, a recombinant parathyroid hormone (PTH), stimulates osteoblasts and has been suggested to improve cancellous bone healing in humans.
Håkan Ledin, Lars Good, Torsten Johansson, Per Aspenberg   +3 more
doaj   +1 more source

Management of Glucocorticoid-Induced Osteoporosis [PDF]

, 2018
This review summarizes the available evidence-based data that form the basis for therapeutic intervention and covers the current status of glucocorticoid-induced osteoporosis (GIOP) management, regulatory requirements, and risk-assessment options ...
Adachi, J., Cooper, C., Dere, W., Devogelaer, J., Diez-Perez, A., Kanis, J., Laslop, A., Mitlak, B., Papapoulos, S., Ralston, S., Reginster, J., Reiter, S., Rizzoli, R., Werhya, G.   +13 more
core  

Denosumab, teriparatide and bisphosphonates for glucocorticoid-induced osteoporosis: a Bayesian network meta-analysis

Frontiers in Pharmacology
Background: Several medications have been used for glucocorticoids-induced osteoporosis (GIO). However, the best therapeutic option for GIO is still controversial.
Liang Dong, Lianghai Jiang, Zhengwei Xu, Xiaobo Zhang   +3 more
doaj   +1 more source

Weekly Injection of Teriparatide for Bone Ingrowth after Cementless Total Knee Arthroplasty

Journal of Orthopaedic Surgery, 2016
Purpose. To compare bone mineral density (BMD) in patients with or without weekly injection of teriparatide to promote bone ingrowth after cementless total knee arthroplasty (TKA). Methods.
Takao Kaneko, Takahiro Otani, Norihiko Kono, Yuta Mochizuki, Takeo Mori, Nobuhito Nango, Hiroyasu Ikegami, Yoshiro Musha   +7 more
doaj   +1 more source